Meeting
2022 ASCO Annual Meeting
Individualized prediction of post-surgical pathologic T3a (pT3a) upstaging risk in localized renal tumors undergoing nephrectomy (UroCCR 15 study).
Authors
Astrid Boulenger de Hautecloque
Bordeaux University Hospital, Bordeaux, France
Astrid Boulenger de Hautecloque , Loïc Ferrer , Guillaume Etchepare , Pierre Bigot , Karim Bensalah , François Henon , Nicolas Doumerc , Arnaud Mejean , Charles Dariane , Stephane Larre , Cecile Champy , Alexandre de la TAILLE , Franck Bruyere , Morgan Roupret , Jean-Jacques Patard , Thibaut Waeckel , Mokrane Yacoub Sr., Philippe Menu , Thierry Colin , Jean-Christophe Bernhard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4547)
DOI
10.1200/JCO.2022.40.16_suppl.4547
Abstract #
4547
Poster Bd #
38
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Prognostic value of loss of chromosome 10q in patients with localized renal cell carcinoma.
First Author: Cedric Michel Lebacle
Poster
2024 ASCO Genitourinary Cancers Symposium
Key parameters that influence surgical strategy in localised kidney cancer.
First Author: Maksym Pikul
Poster
2024 ASCO Genitourinary Cancers Symposium
Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).
First Author: Erica Arenovich
Poster
2024 ASCO Genitourinary Cancers Symposium
Pre-orchiectomy serum miRNA-371a-3p and 372-3p levels in men with clinically localized testicular masses.
First Author: Fady Baky